The Fred Hutchinson Cancer Center (Fred Hutch) and the University of Washington (UW) invite nominations and applications to lead the Leukemia Program. The Program Head will oversee the research and clinical programs in acute myeloid leukemia (AML) and other myeloid malignancies. The position will be dual appointed with a primary faculty appointment in either the Translational Science and Therapeutics Division (Physician/Scientist) or the Clinical Research Division (Clinician/Scholar) at Fred Hutch and a secondary appointment in the UW Department of Medicine, Division of Hematology and Oncology. The position will report to the Senior Vice President (SVP) of their Division at Fred Hutch and the Division Head of Hematology and Oncology at the UW. We anticipate that this individual will actively contribute to our core values of diversity, openness, innovation, and scientific excellence.

We seek a highly motivated, visionary and accomplished scientific and clinical program head to lead our Program. This role offers an exceptional opportunity to drive cutting-edge research, enhance clinical outcomes, help eradicate disparities, and lead a multidisciplinary team in a dynamic and supportive environment.

The Program Head will oversee and strategically guide the Program, ensuring alignment with the institution's mission and goals. They will develop and implement a comprehensive vision and strategy for AML and myeloid malignancies throughout the entire disease spectrum, integrating basic, translational and clinical research with clinical care. The Program Head will lead and/or support groundbreaking research initiatives, including preclinical studies, clinical trials, and translational research and will foster collaborations with bench researchers, translational researchers and clinical investigators at UW and Fred Hutch. The Program Head will serve as an academic, clinical and educational leader charged with organizing, directing and expanding the research efforts for an established team of clinical researchers involved in conducting trials. Responsibilities include assisting with faculty recruitment as well as oversight and mentorship of faculty, promotion of professional development for team members and representation of the Program at national and international conferences, workshops, and symposia. The incumbent will build and maintain strong relationships with external stakeholders, including industry partners, regulatory agencies, and funding organizations.

Competitive candidates will have an international reputation of leadership in AML and/or myeloid malignancies research and clinical excellence. They will have a long-standing track record of substantial basic, translational and/or clinical research with a strong publishing record and NIH grant funding.

Appointment at Fred Hutch would be at the rank of full professor in the Translational Science and Therapeutics Division or Clinical Research Division. Appointment to the full-time faculty at the UW would be at the rank of full professor. Academic appointments at the University of Washington will be commensurate with experience, qualifications, and academic rank. Full professors hold indefinite appointments that align with a 12-month service period (July 1-June 30). Faculty with 12-month service periods are paid for 11 months of service over a 12-month period (July-June), meaning the equivalent of one month is available for paid time off.

Opportunities exist for joint and/or affiliate appointment in the Fred Hutch Divisions of Public Health Sciences, Translational Science and Therapeutics, Clinical Research Division, Human Biology, Basic Sciences, or Vaccine and Infectious Disease, depending on mutual interests. Fred Hutch and University of Washington faculty engage in teaching, research, and service.

The successful candidate will be appointed in the Clinician Scholar or Physician Scientist track and will spend at least 20% of time on clinical care depending on whether the candidate is laboratory-based or a clinical investigator, and taking into account the amount of research funding. The remainder of the incumbent’s time will be protected for research, administrative oversight of the Fred Hutch/UW AML and myeloid malignancies efforts, teaching and mentorship.

Fred Hutch is an independent, nonprofit organization providing adult cancer treatment and groundbreaking research focused on cancer and infectious diseases. Based in Seattle, Fred Hutch is the only National Cancer Institute-designated cancer center in Washington.

With a track record of global leadership in bone marrow transplantation, HIV/AIDS prevention, immunotherapy and COVID-19 vaccines, Fred Hutch has earned a reputation as one of the world’s leading cancer, infectious disease and biomedical research centers. Fred Hutch operates eight clinical care sites that provide medical oncology, infusion, radiation, proton therapy and related services, and network affiliations with hospitals in five states. Together, our fully integrated research and clinical care teams seek to discover new cures to the world’s deadliest diseases and make life beyond cancer a reality.

At Fred Hutch we value collaboration, compassion, determination, excellence, innovation, integrity and respect. These values are grounded in and intentionally expressed through the principles of diversity, equity and inclusion. Our mission is directly tied to the humanity, dignity and inherent value of each employee, patient, community member and supporter. Our commitment to learning across our differences and similarities make us stronger. We seek employees who bring different and innovative ways of seeing the world and solving problems. Fred Hutch is in pursuit of becoming an anti-racist organization. We are committed to ensuring that all candidates hired share our commitment to diversity, anti-racism and inclusion.

This position is paid directly by Fred Hutchinson Cancer Center (Fred Hutch) and receives no UW compensation.  Please refer to Fred Hutch for information about compensation for this position.

Anticipated Start Date: July 1, 2025

Applicants must have:

·       MD/DO degree (or foreign equivalent)

·       Board certification in hematology and/or medical oncology (or foreign equivalent)

·       Eligibility for medical licensure in the state of Washington.

In order to be eligible for University sponsorship for an H-1B visa, graduates of foreign (non-U.S.) medical schools must show successful completion of all three steps of the U.S. Medical Licensing Exam (USMLE) or equivalent as determined by the Secretary of Health and Human Services.  

The ideal candidate will have a record of and primary interest in AML and/or myeloid malignancies research, as demonstrated by peer-reviewed publications, grants and/or clinical trial experience.

Interested candidates should submit the following:

1)     Letter of interest addressed to the Co-Chairs of the Leukemia Program Head Search Advisory Committee, Drs. Jan Abkowitz and Jerry Radich

2)     Curriculum vitae

3)     Personal statement discussing research accomplishments, leadership experience, and outlining a vision for the growth and development of the program (one page)

4)     Diversity, equity, and inclusion statement describing past contributions to diversity, equity, and inclusion and future plans for continuing these efforts (two pages or less)

5)     List of five (5) references (References will not be contacted without first discussing this with the applicant).

The annual base salary range for this position is from $411,251 to $462,657 for faculty hired at the Full Professor rank. Pay for Faculty positions is based on a variety of factors, including degree, specialty, clinical practice and experience. This position is eligible for relocation assistance or a sign-on bonus. Other compensation associated with this position may include an Administrative Supplement (ADS) in addition to base pay.